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Ischemic stroke is a major cause of death and disability all over the world. Ischemic stroke results from a temporary
or permanent reduction of cerebral blood flow that leads to functional and structural damage in different brain
regions. Despite decades of intense research, the beneficial treatment of stroke remains limited. In light of this, the
search for effective means ameliorating cerebral ischemia-reperfusion injury (CIRI) is one of the major problems of
experimental medicine and biology. Recently, the 5-Lipoxygenase (5-LO, a key enzyme metabolizing arachidonic
acid to produce leukotrienes) inhibitors have been showed to protect brain against ischemic damage in animal model
of cerebral ischemia. Caffeic acid, an inhibitor of 5-LO, is a phenolic compound widely distributed in medicinal plants.
The aim of this study was to investigate the effect of caffeic acid on global cerebral ischemia-reperfusion injury in
rats. The study was carried out on 45 rats that were randomly divided into five groups: the sham group (n = 9), I/R
non-treated group (n = 9), I/R-caffeic acid group (10 mg · kg−1) (n = 9), I/R-caffeic acid group (30 mg · kg−1) (n = 9) and
I/R-caffeic acid group (50 mg · kg−1) (n = 9). Global cerebral ischemia was induced by bilateral carotid artery occlusion
for 20 min followed by reperfusion. Spatial learning and memory was evaluated using Morris water maze.
Histopathological changes of hippocampus neurons was observed using HE staining. Superoxide dismutase
(SOD, the antioxidant enzyme) activities and malondialdehyde (MDA, an oxidative stress biomarker) contents
were detected. NF-κBp65 expression was detected by the methods of immunohistochemistry. Caffeic acid
markedly reduced the escape latency, relieved hippocampal neurons injury and increased neuron count
compared with those of I/R non-treated rat. NF-κBp65 expression and MDA content decreased significantly,
and SOD activities increased significantly in hippocampus. Compared with sham group, 5-LO expression increase
significantly in I/R non-treated group rat, and caffeic acid markedly reduced 5-LO expression. The results of the
study suggest that caffeic acid has a significant protective effect on global cerebral ischemia-reperfusion injury in
rats. The neuroprotective effects is likely to be mediated through the inhibition of 5-LO.
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Ischemic stroke is a major cause of death and disability
all over the world [1]. Indeed, it is the third leading
cause of death, after heart disease and cancer, and the
leading cause of long-term disability in major industrial-
ized countries [2]. Ischemic stroke results from a tempor-
ary or permanent reduction of cerebral blood flow that
leads to functional and structural damage in different
brain regions. Cellular damage occurs during ischemia
[3,4] and reperfusion [5,6]. Despite decades of intense* Correspondence: cqjqyang2004@aliyun.com
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ited [7]. In light of this, the search for effective means
ameliorating cerebral ischemia-reperfusion injury (CIRI) is
one of the major problems of experimental medicine and
biology [8].
Currently, the mechanisms of neuronal injury and
death induced by cerebral ischemia-reperfusion (I/R) are
not completely known. Recently, 5-Lipoxygenase (5-LO),
a key enzyme metabolizing arachidonic acid to produce
leukotrienes [9,10], has been reported to be involved in
brain injury [11,12]. 5-LO expression is increased and
leukotriene contents are elevated in the ischemic brain
[13-16], indicating a role of 5-LO in cerebral ischemia.
The importance of 5-LO in stroke has been proven byhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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ing protein confers risk of stroke [17-19]. The 5-LO inhibi-
tors have been showed to protect brain against ischemic
damage in animal model of cerebral ischemia [20-23].
Caffeic acid (3,4-dihydroxycinnamic acid, CA) is a phen-
olic compound widely distributed in medicinal plants,
including fruits, vegetables, wine, coffee and olive oil,
among others, and is therefore present in human plasma
in a diet dependent concentration [24-26]. CA has been
shown to be an inhibitor of 5-LO [27,28], and it is an intri-
guing compound because it possesses various pharmaco-
logical activities, including antioxidants [29-32], metal
chelating agent [33], antihypertensive [34], antifibrosis
[35,36], antiviral [37-39], anti-cancer [40], antidepressive
[41,42], anti-inflammatory [43-45] and antidiabetic [46,47]
properties. Recently neuroprotective effect of CA has also
been suggested [48-51]. Previous studies have related
an important protective effect of CA on focal cerebral
ischemia-reperfusion injury [12]. However, its neuropro-
tective effect on global cerebral ischemia-reperfusion in-
jury remains unclear. Thus, the aim of this study was to
investigate the effect of CA on global cerebral ischemia-




Caffeic acid was purchased from Sigma Chemical Com-
pany (St. Louis, MO, USA). All other chemicals and bio-
chemicals used for the experiments were of analytical
grade obtained from local firms.
Animals and experimental procedures
A total of 45 Male Sprague–Dawley rats (200–250 g)
were purchased from the Laboratory Animal Center of
Chongqing Medical University, Chongqing, China. Rats
were housed in standard conditions of 25 ± 1°C, 50 ± 2%
humidity, with 12/12 h light/dark cycles (light from
8:00–20:00) and ad libitum access to water and standard
pellet food. All experiments were carried out in accord-
ance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals, and were approved
by the Medical Ethics Committee of Chongqing Medical
University. The animal application approval number
was SCXK2007-0001, which was given by the Chongqing
Science and Technology Commission in September 2007.
Experimental design
Rats were divided into five groups: the sham group (n = 9),
I/R non-treated group (n = 9), I/R-caffeic acid group
(10 mg · kg−1) (n = 9), I/R-caffeic acid group (30 mg · kg−1)
(n = 9) and I/R-caffeic acid group (50 mg · kg−1) (n = 9). In
I/R-caffeic acid groups, the rats were administrated caffeic
acid at 10, 30, 50 mg · kg−1 (prepared with 0.3% sodiumcarboxymethyl cellulose) by intraperitoneal injection at
30 min prior to ischemia. The sham group and I/R group
were treated with an equal volume of 0.3% sodium car-
boxymethyl cellulose.Induction of global cerebral I/R model
Rats were anesthetized by intraperitoneal injection of
chloral hydrate (400 mg/kg), and fixed in a supine pos-
ition. Global cerebral ischemia was induced as previously
described [52,53]. A midline incision was made in the
neck, after that the incision was extended 1 cm to the
right. Then both common carotid arteries and the right
common jugular vein were exposed carefully by blunt
dissection. The distal end of the common jugular vein
was ligated following 2 ml heparinized saline (100 mL
0.9% saline containing heparin (250 U)) were perfused.
The blood accounting for about 30 percent of the total
blood volumes were taken from the right common jugu-
lar vein leading to hypotension. Global cerebral ischemia
was induced by bilateral clamping of the common ca-
rotid arteries combined with hypotension. After ischemia
for 20 min, the artery clamps were removed, and the ex-
tracted blood was reinfused. Rats in the sham group
were subjected to the same operation as above, excepted
for the bilateral carotid artery occlusion and hemospasia
from the right common jugular vein.
Morris water maze test
At the 8th day after global cerebral I/R, the rats’ spatial
learning and memory was assessed by the Morris water
maze test, which consisted of 4-day training (at about
the same time (5:00 – 10:00 pm)) and 1-day test. This
was carried out as described previously [54,55] with
some modifications. Rat spatial learning and memory
were tested using a DMS-2 Morris water maze (Institute
of Materia Medica, Chinese Academy of Medical Sci-
ences, Beijing, China) (150 cm diameter, 50 cm height)
filled to a depth of 40 cm with water maintained at 24-
25°C. An invisible platform (25 cm in diameter) was sub-
merged 2 cm below the water surface and placed at the
midpoint of one quadrant. During the training, the rats
(n = 9 in each group) were sent into the water separately
and forced to seek the platform (safety island) by swim-
ming. If the rats found the platform within 180 s, it was
allowed to stay on the platform for 10 s, otherwise, it
was gently navigated to the platform by hand for 10 s.
The rats were subjected to four trials with a 1-h interval
between trials every day. On the fifth day, the platform
was removed and the rat was put into the water at the
same place as before. The time for the rat to pass
through the place, where the platform was previously
placed, was called as the time for exploring platform.
The time for exploring platform was recorded using a
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test apparatus. The cut out time was 180 s.
Histopathological examination
After spatial memory evaluation, rats (n = 3) in each group
were anesthetized with 4% chloral hydrate (400 mg/kg,
ip). Then, the rats were perfused transcardially with 4%
paraformaldehyde after a pre-wash with 100 mL 0.9%
saline containing heparin (250 U). The brain tissue was
isolated and fixed in 4% paraformaldehyde for 3–5 days.
Then the brain tissue was cutted into thin blocks, and fix-
ing in 95% ethanol and carrying out the subsequent dehy-
dration and clearing at refrigerator temperatures (4°C).
Thereafter, embedding in paraffin, and then coronal sec-
tions of 5 μm in thickness were cut from each block. The
sections were stained with hematoxylin and eosin (H&E).
The histomorphology of neurons in each rat hippocampus
was observed by light microscopy. For assessment of cell
counts from H&E-stained sections, 10 consecutive high-
power fields were sampled from the dorsal hippocampal
CA1 subfield. Pyramidal cells with a distinct nucleus and
nucleolus were regarded as intact, while neurons showing
typical signs of dark staining, shrinkage and dysmorphic
shape were considered as damaged. Counts of intact neu-
rons were performed from the ischemic and sham brains
using a microscope at 400 x magnification, and the extent
of cell death was estimated, expressed as percentage for
each hippocampal region.
Reverse transcription-polymerase chain reaction (RT-PCR)
After spatial memory evaluation, rats (n = 3) in each group
were sacrificed (total of 15 rats). Brains were removed, and
the hippocampi were separated. To determine 5-LO mRNA
expression after ischemia, total RNA was extracted from
the cerebral hippocampus of rats using Trizol reagents
following the procedures described in manufacturer’s in-
structions. Total RNA integrity was identified using 0.8%
agarose gel electrophoresis, and RNA purity and concentra-
tion were determined using ultraviolet spectrophotometry.
Total RNA concentration was adjusted to 1.0 μg/μL.
For the cDNA synthesis, the total reaction volume for
RT was 20 μL, including 4 μL 5 × PrimeScriptTM Buffer,
2 μL 10 mM dNTP, 0.5 μL 40 U/μL RNase inhibitor,
2 μL 2.5 μM oligo (dT) Primer, 8 μg of RNA template,
0.5 μL PrimeScriptTM RTase and 5 μL RNase-free dH2O.
The mixture was incubated at 42°C for 20 min, 95°C for
5 min, 4°C for 15 min to inactivate the reverse transcript-
ase. PCR was performed as follows: 2.5 μL cDNA mixture
was reacted in the reaction buffer (25 μL) containing
12.5 μL Premix Taq, 0.5 μL forward primers, 0.5 μL re-
verse primers and 9 μL sterile double-distilled water. The
thermal cycling conditions for the PCR involved an initial
denaturation step at 94°C for 3 min followed by 35 cycles
at 94°C for 30 s, 55°C for 30 s and 72°C for 45 s, finallystopped at 72°C for 5 min. PCR products were separated by
2% agarose gel electrophoresis and visualized by ethidium
bromide staining. The absorbance value of 5-LO and
β-actin mRNA was measured using a Bio-Rad gel imag-ing
analysis system (Bio-Rad Laboratories). The absorbance
ratio of 5-LO mRNA to β-actin mRNA was defined as the
5-LO mRNA relative quantity. The primer sequences for
5-LO were: forward 5′-TGTACCCAGAGGAGCAT-3′and
reverse 5′-ACGGCAAAGCCTTAGAT-3′; which results in
a PCR product of 177 bp. Those for β-actin were: forward
5′-AAGATCCTGACCGAGCGTGG-3′ and reverse 5′-CA
GCACTGTGTTGGCATAGAGG-3′; which results in a PCR
product of 318 bp.
Western blotting
After spatial memory evaluation, rats (n = 3) in each group
were sacrificed, and brains were removed. Rat hippocam-
pus were chopped into small pieces, homogenized in
0.5 ml of RIPA buffer. The dissolved proteins were col-
lected from the supernatant after centrifugation at 12
000 × g at 4°C for 5 min. The supernatant was collected
for Western blotting analysis. The protein concentration
of the supernatant were determined with the BCA Protein
Assay reagent kit following the manufacturer’s protocols.
Equal amounts of protein samples were separated by SDS/
PAGE and then transferred to PVDF membranes. The
membranes were blocked with 5% skim milk for 2 h and
incubated with rabbit anti-5-LO (1: 300; Beijing Boaosen
Biotechnology Co., Ltd., Beijing, China) and rabbit anti-β-
actin polyclonal antibody (1: 1 000; Beijing Boaosen
Biotech-nology Co., Ltd., Beijing, China) at 4°C overnight.
After washing with TBST, the membranes were incubated
with a horseradish peroxidase-conjugated secondary anti-
body (1:2000) for 2 h at 37°C. Finally, the membranes were
reacted with the ECL reagents and exposed on an X-ray
film. The optical densities of 5-LO and β-actin bands on
the X-ray film was measured using a Bio-Rad gel imaging
analysis system (Bio-Rad Laboratories). The results were
expressed as 5-LO/β-actin ratios.
Biochemistry
After spatial memory evaluation, 3 rats from each group
were sacrificed and the hippocampi were dissected. The
hippocampus (100 mg) was homogenized with saline
(tissue: saline = 1:9). The malondialdehyde (MDA) content
and the activities of superoxide dismutase (SOD) were
measured using the biochemistry assay kit (Jiancheng Bio-
engineering Ltd, Nanjing, China) according to the manu-
facturer’s manual. The protein content of samples was
measured using biuret reaction.
NF-κBp65 immunohistochemistry
The paraffin sections (the same as those for H&E staining)
were used for immunohistochemical assays following the
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in xylene and hydrated through a series of graded ethanol,
and washed thrice with PBS (0.02 mmol/L, pH 7.4) for
3 min. The sections were incubated with 3% H2O2 for
10 min. After the section was rinsed for 3 min × 3 with
PBS, the rehabilitation of antigen was performed by
microwave oven. Then the sections were incubated with a
polyclonal antibody to NF-κBp65, (diluted 1:100) over-
night at 4°C. The sections were rinsed for 3 min × 3 with
PBS before incubation with biotinylated goat anti-rabbit
IgG antibody for NF-κBp65, for 40 min at 37°C, and
incubated with streptavidin for 20 min,and then rinsed
for another 3 min × 3 with PBS before reaction with
DAB solution. The sections were counterstained with
hematoxylin and then observed under a microscope.
The absorbance value of 5-LO and β-actin mRNA was
measured using a Bio-Rad gel imaging analysis system
(Bio-Rad Laboratories). The absorbance ratio of 5-LO
mRNA to β-actin mRNA was defined as the 5-LO
mRNA relative quantity.Statistical analysis
Experimental data are expressed as Means ± SD. Analysis
of variance was performed using the SPSS 17.0 statistical
software package (SPSS, Chicago, IL, USA), with signifi-
cance of differences within-group and between-group
analyzed by Dunnett’s test. Statistical significance was
considered when P < 0.05.Results
Changes in learning and memory function in rats
There was a significant difference between all groups for
the time spent in finding platform. Compared with the
sham group, the time taken to find platform was signifi-
cantly longer in the I/R non-treated group (P < 0.01).
Compared with the I/R non-treated group, the latency
to find platform was significantly shortened in low- and
high-dose caffeic acid groups, the shortened platform la-
tency was most evident in the I/R-caffeic acid group
(50 mg · kg−1) (P < 0.01) (Table 1).Table 1 Exploring time of rats (x  s,n = 9)
Exploring time(s)
d1 d2
Sham 112.46 ± 16.14 72.33 ± 15.20a
I/R 166.79 ± 23.7** 129.05 ± 8.3**a
I/R-caffeic acid (10 mg · kg−1) 164.22 ± 19.6 94.16 ± 25.45#
I/R-caffeic acid (30 mg · kg−1) 148.84 ± 17.6# 89.11 ± 9.88#aa
I/R-caffeic acid (50 mg · kg−1) 126.48 ± 3.26# 70.99 ± 9.63##a
**P < 0.01 vs Sham group; #P <0.05, ##P < 0.01 vs I/R group; aP < 0.05, aaP < 0.01 vs d1
4-day training; d5: 1-day test.Morphological changes of rat hippocampus
Results showed that the neurons in the control group were
closely arranged, well-structured, had a clear and normal
cell morphology, and a pyknosis ratio was calculated at
(13.3 ± 2.3)%. In the I/R non-treated group, karyopyknosis
was evident, the number of neurons was reduced, and
pyknosis ratio was (88.2 ± 1.9)%. In the low-dose caffeic
acid group, cell injury was still marked, the pyknosis ratio
was (63.6 ± 2.8)%, whereas in the high-dose caffeic acid
group, hippocampal neuron karyopyknosis was significantly
reduced and the pyknosis ratio was (13.3 ± 3.0)% (Figure 1).
Changes in 5-LO mRNA expressions
Results showed that expression of 5-LO mRNA signifi-
cantly increased in I/R non-treated rat hippocampus
(P < 0.01). Caffeic acid significantly reduced the expres-
sion of 5-LO mRNA(P < 0.01) dose-dependently in
hippocampus (Figure 2).
Changes in 5-LO protein expressions
Results showed that global cerebral ischemia-reperfusion
injury can lead to a marked increase of 5-LO protein ex-
pression (P < 0.01) in the hippocampus. Compared with
the I/R non-treated group, 5-LO protein expression sig-
nificantly reduced in the I/R-caffeic acid group (P < 0.05
or P < 0.01), especially in the I/R-caffeic acid group
(50 mg · kg−1) (Figure 3).
Changes in SOD activity and MDA content
Results showed that SOD activity decreased and MDA
content increased markedly in the I/R non-treated group
when compared with the sham group. The change of
MDA levels and SOD activity were antagonized after
treatment with caffeic acid, especially with caffeic acid
(30 mg · kg−1) and caffeic acid (50 mg · kg−1) (Table 2).
Changes in protein expression of NF-κBp65
Immunohistochemistry results showed that the protein
expression of NF-κBp65 in the I/R non-treated group
was distinctly elevated (77.3 ± 5.5)%, compared with the
sham group (12.5 ± 4.6)% (P < 0.01). Besides, the protein
expression of NF-κBp65 translocated from the cytosol tod3 d4 d5
a 42.48 ± 3.50b 23.25 ± 2.30c 18.78 ± 2.70d
77.53 ± 2.3**bb 65.73 ± 8.3**c 42.48 ± 3.50**d
aa 53.95 ± 5.3#bb 45.35 ± 5.3#c 26.04 ± 3.19##d
46.71 ± 6.5#bb 31.88 ± 3.9##cc 23.70 ± 1.49##
a 43.95 ± 4.1##b 25.01 ± 0.4##cc 20.23 ± 8.85##
; bP < 0.05, bbP < 0.01 vs d2; cP < 0.05, ccP < 0.01 vs d3; dP < 0.05 vs d4; d1-d4:
Figure 2 Effects of caffeic acid on 5-LO mRNA expression after global cerebral ischemia and reperfusion injury in rat hippocampus (mean ± SD, n = 9).
**P < 0.01 vs sham group; #P < 0.05 and ##P < 0.01 vs IR group.
Figure 1 Histopathology of rat hippocampus (HE×400). A: Sham group; B: I/R; C: I/R + Caffeic acid (10 mg · kg−1); D: I/R + Caffeic acid (30 mg · kg−1); E:
I/R + Caffeic acid (50 mg · kg−1). B: Effects of Caffeic acid on morphological changes of hippocampus neurons of rats after global cerebral ischemia/
reperfusion(mean ± SD, n = 4). ##P < 0.01 compared with Sham group, *P < 0.05 and **P < 0.01 compared with IR group.
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Figure 3 Effects of caffeic acid on 5-LO protein expression after global cerebral ischemia and reperfusion injury in rat hippocampus(mean ± SD, n = 9).
**P < 0.01 vs sham group; #P < 0.05, ##P < 0.01, vs model group.
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I/R non-treated group. However, administration of caf-
feic acid (30 and 50 mg/kg) significantly reduced the glo-
bal cerebral I/R-induced elevation of NF-κBp65 protein
expressions level and increased the cytosolic NF-κBp65
level even though administration of caffeic acid 10 mg/kg
had no effect on the global cerebral I/R-induced elevation
of NF-κBp65 protein expressions level and the cytosolic
NF-κBp65 level (Figure 4).
Discussion
Caffeic acid is an active component in the phenolic prop-
olis extract and also in a wide variety of plants. It has been
reported to have anti-inflammatory, anti-apoptotic, and
anti-oxidative properties. In this study, we found thatTable 2 SOD activity and MDA content of rat
hippocampus (x s, n = 4)
SOD MDA
/U · mg−1 Pro /ěmol•g−1Pro
Sham 11.05 ± 0.65 0.42 ± 0.04
I/R 7.13 ± 0.38** 1.08 ± 0.07**
I/R + Caffeic acid (10 mg · kg−1) 8.21 ± 0.28# 0.91 ± 0.14#
I/R + Caffeic acid (30 mg · kg−1) 10.30 ± 0.01## 0.70 ± 0.05##
I/R + Caffeic acid (50 mg · kg−1) 10.69 ± 0.64## 0.52 ± 0.07##
**P < 0.01vs sham operation group;#P < 0.05,##P < 0.01vs nodel group.caffeic acid had neuroprotective effects on global cerebral
ischemia-reperfusion injury in rats. The study also pro-
vides evidence that the mechanism of this protective effect
may relate to the inhibition of 5-LO.
Our experimental results showed that global cerebral
ischemia-reperfusion impaired learning and memory
functions of rats. Compared with the sham group, the
time taken to find platform was significantly longer in
the I/R non-treated group. Global cerebral ischemia-
reperfusion also causes neuronal death and loss of
neurons in CA1 subfield of hippocampus. In the sham
group, the neurons were closely arranged, well-structured,
had a clear and normal cell morphology, and the pyknosis
ratio was low. In the I/R non-treated group, the neurons
were disorder, the morphology of the neurons was not
clear, the number of neurons was reduced, karyopyknosis
was evident, and pyknosis ratio was increased significantly.
It also elevated 5-LO mRNA, 5-LO protein and NF-κBp65
protein expression. Results suggested a close correlation
between global cerebral ischemia-reperfusion injury in
rats and 5-LO expression in hippocampus. Similar results
were reported [13-16] that ischemia-reperfusion injury
increased 5-LO mRNA expression, production of LTC4,
translocation of cytosolic 5-LO to membranes, and gener-
ation of oxygen radicals. Y. Zhou et al. [56] also found that
the 5-LO expression and the enzymatic activity increased
after focal cerebral ischemia. Taken together, these results
Figure 4 Expression of NF-κBp65in hippocampal neurons of rats (HE × 400). A: Sham group; B: I/R group; C: I/R + Caffeic acid (10 mg · kg−1) group;
D: I/R + Caffeic acid(30 mg · kg−1) group; E: I/R + Caffeic acid (50 mg · kg−1) group. B: Effects of Caffeic acid on NF-κBp65 expression in hippocampus of
rats after global cerebral ischemia/reperfusion (mean ± SD, n = 3).
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tionship between overexpression of 5-LO and neuronal
damage caused by global cerebral ischemia-reperfusion.
Our results also revealed that caffeic acid, a selective
5-LO inhibitor, protected rats from neuronal damage
induced by global cerebral ischemia-reperfusion. It can
significantly improve learning and memory function.
Caffeic acid antagonized the global cerebral ischemia-
reperfusion induced increase in brain MDA levels and
the decrease in SOD activity. It downregulated the over-
expression of NF-κBp65 protein, as well as 5-LO mRNA
and protein expression. The results provided direct
evidence that caffeic acid has a significant neuroprotec-
tive effect on global cerebral ischemia-reperfusion injury
with biochemical and histopathological parameters. These
results also suggested that the protective effects of caffeic
acid might be related to reduced 5-LO expression [12,28].
The results is consistent with previous reports [57]
that minocycline accelerates functional recovery in the
chronic phase of focal cerebral ischemia, which may be
partly associated with the reduction of 5-LO expression.
Similarly, as a 5-LO inhibitor, nordihydroguaiaretic acid
also have neuroprotective effect on focal cerebral
ischemia-reperfusion injury through inhibiting 5-LO
and inflammatory responses mediated by 5-LO metabo-
lites [16].In this study, we could not explain the mechanism by
which caffeic acid reduces 5-LO expression. However,
as we know that inflammation and oxidative stress can
cause neuronal injury, which further cause the increase
of expression of inflammation-related enzyme. On the
one hand, the possibility is that caffeic acid reduces re-
active oxygen species (ROS) production, which may in-
hibit 5-LO expression. Our experimental results showed
that global cerebral ischemia-reperfusion reduced the ac-
tivity of SOD (an eliminator of free radicals), increased the
content of MDA(an indicator of lipid peroxidation) and
NF-κBp65 (an important transcription factor that plays a
pivotal role in mediating inflammatory response to pro-
inflammatory cytokines and ROS) protein expression. The
consequent oxidative stress and overproduction of ROS
during ischemia-reperfusion event has a critical role for
the level of brain injury [58,59]. There is a lot of evidence
in many studies that accumulation of ROS through I/R
causes neuronal damage and increases the occurrence of
apoptotic cell death in the brain [60-62]. The results also
revealed that caffeic acid, a selective 5-LO inhibitor, antag-
onized the global cerebral ischemia-reperfusion induced
increase in brain MDA levels and the decrease in SOD ac-
tivity. It downregulated the overexpression of NF-κBp65
protein. In a word, caffeic acid ameliorates the oxidative
stress following global cerebral ischemia-reperfusion
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[63,64]. Caffeic acid reduces reactive oxygen species
(ROS) production, which may inhibit 5-LO expression.
This hypothesis is supported by the finding that minocy-
cline reduces ROS production, such as peroxyl radicals
[65], hydroxyl radicals [66] and superoxide anion, which
in turn inhibits 5-LO expression and decreases leukotri-
ene synthesis [67]. On the other hand, caffeic acid could
inhibit oxidative stress and reduce the release of inflam-
matory factor leukotriene synthesis by inhibition of
5-LO. This could decrease the neuronal injury, which in
turn caused decrease of the 5-LO expression by feed-
back regulation.
The mechanisms of the neuroprotective effects of caf-
feic acid on global cerebral ischemia-reperfusion injury
are not fully understood, but the effects can be explained
at least in two ways. One is its anti-oxidant and anti-
inflammatory ability as shown in lots of studies. Like
CAPE, caffeic acid as an antioxidant can scavenge a
number of reactive species. In the present study, we con-
firmed the anti-oxidant ability of caffeic acid after global
cerebral ischemia-reperfusion injury. We found that glo-
bal cerebral ischemia-reperfusion injury reduces the ac-
tivity of SOD and increases the amount of MDA. These
changes can be inhibited by caffeic acid, similar as by
edaravone, an anti-oxidant agent with neuroprotective
effects [63,64]. Another explanation for the protective ef-
fects of caffeic acid is the inhibition of 5-lipoxygenase
(5-LO) activity [27]. 5-LO activation is related to cell in-
jury and can be inhibited by caffeic acid. It was reported
that 5-LO enzymatic activity was increased and its ex-
pression was up-regulated in focal cerebral ischemia,
and the increased 5-LO enzymatic activity was inhibited
by caffeic acid [12]. Therefore, caffeic acid might attenu-
ate astrocyte proliferation and glial scar formation via
inhibiting 5-LO activity.
Nevertheless, further evidence should be obtained from
experimental and clinical studies to confirm our hypoth-
esis. Considering that COX-2 is a similar inflammatory
mediator, catalyzing the conversion of arachidonic acid
into prostaglandins, it should be of interest to investigate
whether a combination of 5-LO and COX-2 inhibitors
would exert a more pronounced effect on global cerebral
ischemia-reperfusion injury than either inhibitor alone.Conclusion
In summary, caffeic acid has neuroprotective effects on
global cerebral ischemia-reperfusion injury in rats, as
shown by the decrease in MDA overproduction, increase
in SOD activity of the hippocampus. The neuroprotec-
tive effect is likely to be mediated through the inhibition
of 5-LO. These findings suggest that caffeic acid may
represent a new prototype compound of potentialneuroprotective agents in the treatment of global cere-
bral ischemia-reperfusion injuries.
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